Intelligence · Clinical pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
Pipeline programs
-
Famciclovir 500 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Fasinumab
Regeneron UK Limited
Healthy Volunteers
1 trial -
Fasinumab AI
Regeneron UK Limited
Osteoarthritis, Knee
1 trial -
Fast Dual CAR-T Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-cell Lymphoma
1 trial -
Faster Aspart
Novo Nordisk A/S
Diabetes Mellitus, Type 1
1 trial -
Fazirsiran
Takeda
Hepatic Impairment
1 trial -
Febuxostat XR
Takeda
Gout
1 trial -
Febuxostat XR
Takeda
Healthy Volunteers
1 trial -
Febuxostat XR 80 mg Capsule F1
Takeda
Healthy Volunteers
1 trial -
Fecal Microbiota Transplant (FMT)
MAIA Biotechnology
Chronic Pouchitis
1 trial -
Fecal Microbiota Transplantation
Finch Therapeutics Group
Enterobacteriaceae Infections
1 trial -
Fenfluramine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Ferric Carboxymaltose Injection
The First People's Hospital of Lianyungang
Healthy Adult
1 trial -
Ferumoxytol
LIPELLA PHARMACEUTICALS INC.
IC - Interstitial Cystitis
1 trial -
Fexofenadine
LEXICON PHARMACEUTICALS, INC.
Drug Interactions
1 trial -
Fexofenadine 180 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Fexofenadine Hydrochloride without sodium lauryl sulfate
BRIGHT MINDS BIOSCIENCES INC.
The Impact of Excipients on Drug Absorption
1 trial -
Filgotinib
Lakefront Biotherapeutics NV
Bioavailability
1 trial -
Filgrastim
Rocket Pharmaceuticals B.V.
Fanconi Anemia
1 trial -
Fimasartan
BRIGHT MINDS BIOSCIENCES INC.
Hypertension
1 trial -
Fimasartan
Yung NA
Hypertension
1 trial -
Fimasartan
Yung NA
Essential Hypertension
1 trial -
Fimasartan/Atorvastatin Combination Tablet
Yung NA
Hypertension
1 trial -
Finasteride 5 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Firibastat
Quantum Biopharma
Healthy Males
1 trial -
First in human study of the infusion of ARI00...
The George Institute
Relapsed/refractory B-cell aggressive lymphoma
1 trial -
First-in-Human Study of RO7812653
Hoffmann-La Roche
Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairment due to AD, or probable AD dementia)
1 trial -
First-in-Human Trial of DS3610a in Participants with Advanced Solid Tumors
Daiichi Sankyo
Advanced Solid Tumors
1 trial -
First-in-Human trial of DS9051b in participants with advanced solid tumors
Daiichi Sankyo
Advanced or Metastatic Adrenocortical Carcinoma (ACC), Metastatic Castration-resistant Prostate Cancer (CRPC)
1 trial -
First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors
Daiichi Sankyo
Advanced Solid Tumors
1 trial -
First-in-human Trial of DS-2243a in Participants with Advanced Solid Tumors
Daiichi Sankyo
Advanced Solid Tumor
1 trial -
Fixed dose combination Ciprofloxacin/Celecoxib
NeuroSense Therapeutics
ALS (Amyotrophic Lateral Sclerosis)
1 trial -
Fluconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
Fludarabine
Zafatek
Hematologic Malignancies
1 trial -
Fluoxetine Hydrochloride
Teva Pharma GmbH
Healthy
2 trials -
Fluticasone Propionate MDPI
Teva Pharma GmbH
Asthma
1 trial -
Folic Acid 5 MG
The University of Hong Kong
Acute Kidney Injury
1 trial -
Follicle Stimulating Hormone Receptor T Cells
Anixa Biosciences Inc
Ovarian Cancer
1 trial -
Fospropofol disodium
Hospital Authority, Hong Kong
Drug Safety
1 trial -
Fospropofol disodium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Drug Safety
1 trial -
Fostamatinib
RIGEL PHARMACEUTICALS INC
Chronic Graft Versus Host Disease
1 trial -
Fostamatinib 100 mg bid and Paclitaxel
RIGEL PHARMACEUTICALS INC
Ovarian Cancer
1 trial -
Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)
RIGEL PHARMACEUTICALS INC
Pancreatic Ductal Adenocarcinoma (PDAC)
1 trial -
Four naloxone nasal spray doses (1 every 2.5 min)
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
Freethiadine tablets(part I)
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hepatitis B, Chronic
1 trial -
Fucoidan (extract of Laminaria japonica)
Takeda
Healthy Volunteers
1 trial -
Furmonertinib
ArriVent BioPharma
Non-Small Cell Lung Cancer (NSCLC)
1 trial -
G060-A5
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.